TL1A Produced by Lamina Propria Macrophages Induces Th1 and Th17 Immune Responses in Cooperation with IL-23 in Patients with Crohn's Disease

被引:103
作者
Kamada, Nobuhiko
Hisamatsu, Tadakazu
Honda, Haruki
Kobayashi, Taku
Chinen, Hiroshi
Takayama, Tetsuro
Kitazume, Mina T.
Okamoto, Susumu
Koganei, Kazutaka [2 ]
Sugita, Akira [2 ]
Kanai, Takanori
Hibi, Toshifumi [1 ]
机构
[1] Keio Univ, Sch Med, Dept Internal Med,Div Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1608582, Japan
[2] Yokohama Municipal Citizens Hosp, Dept Surg, Yokohama, Kanagawa, Japan
关键词
inflammatory bowel disease; Crohn's disease; macrophage; TL1A; IL-23; INFLAMMATORY-BOWEL-DISEASE; IFN-GAMMA PRODUCTION; ULCERATIVE-COLITIS; T-CELL; CYTOKINE; TNFSF15; COSTIMULATOR; PATHOGENESIS; SUSCEPTIBILITY; INTERLEUKIN-12;
D O I
10.1002/ibd.21124
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Tumor necrosis factor (TNF)-like protein 1A (TL1A) is a member of the TNF superfamily and contributes to the pathogenesis of Crohn's disease (CD) by stimulating T-helper (Th) 1 cells. In addition to Th1, recent studies have focused on the role of Th17 cells in the pathogenesis of CD. Here we tried to clarify the role of TL1A in Th1 and Th17 immunity in CD. Methods: TL1A expression was assessed by quantitative reverse-transcription polymerase chain reaction (RT-PCR) in lamina propria (LP) macrophages (LP-M phi s) from normal controls (NC) and patients with CD or ulcerative colitis (UC). Purified LP CD4(+) T cells were stimulated with TL1A and/or IL-23 and interferon gamma (IFN-gamma) and interleukin (IL)-17 levels were analyzed. We also examined the effect of TL1A on naive CD4(+) T-cell differentiation. Results: We found that LP-M phi s are a major producer of TL1A. TL1A expression was markedly enhanced in LP-M phi s from CD patients compared with NC or UC patients. IL-23, in addition to TL1A, was induced in LP-M phi s by commensal bacteria stimulation. TL1A and IL-23 synergistically promoted the production of IFN-gamma and IL-17 by LP T cells, while TL1A alone did not induce cytokine production. Furthermore, TL1A promoted Th17 differentiation from naive T cells by LP-M phi s: however, IL-23 did not show any synergistic effects on Th17 differentiation. Conclusions: TL1A expressed in LP-M phi s might play an important role in the pathogenesis of CD by inducing Th1 and Th17 immunity. IL-23 differentially regulated these functions of TL1A on memory and naive T cells.
引用
收藏
页码:568 / 575
页数:8
相关论文
共 29 条
[1]   IL-23 and Autoimmunity: New Insights into the Pathogenesis of Inflammatory Bowel Disease [J].
Abraham, Clara ;
Cho, Judy H. .
ANNUAL REVIEW OF MEDICINE, 2009, 60 :97-110
[2]   Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease [J].
Bamias, G ;
Martin, C ;
Marini, M ;
Hoang, S ;
Mishina, M ;
Ross, WG ;
Sachedina, MA ;
Friel, CM ;
Mize, J ;
Bickston, SJ ;
Pizarro, TT ;
Wei, P ;
Cominelli, F .
JOURNAL OF IMMUNOLOGY, 2003, 171 (09) :4868-4874
[3]   Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis [J].
Bamias, Giorgos ;
Siakavellas, Spyros I. ;
Stamatelopoulos, Kimon S. ;
Chryssochoou, Elda ;
Papamichalel, Christos ;
Sfikakis, Petros P. .
CLINICAL IMMUNOLOGY, 2008, 129 (02) :249-255
[4]   The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis [J].
Bull, Melanie Jane ;
Williams, Anwen Sian ;
Mecklenburgh, Zarabeth ;
Calder, Claudia Jane ;
Twohig, Jason Peter ;
Elford, Carole ;
Evans, Bronwen Alice James ;
Rowley, Tania F. ;
Slebioda, Tomasz J. ;
Taraban, Vadim Y. ;
Al-Shamkhani, Aymen ;
Wang, Eddie Chung Yern .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (11) :2457-2464
[5]   The genetics and immunopathogenesis of inflammatory bowel disease [J].
Cho, Judy H. .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (06) :458-466
[6]   Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain [J].
Cua, DJ ;
Sherlock, J ;
Chen, Y ;
Murphy, CA ;
Joyce, B ;
Seymour, B ;
Lucian, L ;
To, W ;
Kwan, S ;
Churakova, T ;
Zurawski, S ;
Wiekowski, M ;
Lira, SA ;
Gorman, D ;
Kastelein, RA ;
Sedgwick, JD .
NATURE, 2003, 421 (6924) :744-748
[7]   Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody [J].
Fuss, IJ ;
Becker, C ;
Yang, ZQ ;
Groden, C ;
Hornung, RL ;
Heller, F ;
Neurath, MF ;
Strober, W ;
Mannon, PJ .
INFLAMMATORY BOWEL DISEASES, 2006, 12 (01) :9-15
[8]  
Fuss IJ, 1996, J IMMUNOL, V157, P1261
[9]   Novel pathophysiological concepts of inflammatory bowel disease [J].
Hibi, T ;
Ogata, H .
JOURNAL OF GASTROENTEROLOGY, 2006, 41 (01) :10-16
[10]   IL-23/IL-17 immunity as a hallmark of Crohn's disease [J].
Holtta, Veera ;
Klemetti, Paula ;
Sipponen, Taina ;
Kociubinski, Guillermo ;
Westerholm-Ormio, Mia ;
Solo, Horri ;
Rasanen, Loura ;
Kolho, Kaija-Leena ;
Farkkila, Martti ;
Savilahti, Erkki ;
Vaarala, Outi .
INFLAMMATORY BOWEL DISEASES, 2008, 14 (09) :1175-1184